External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19
Mark Goldin, Stephanie K. Lin, Nina Kohn, Michael Qiu, Stuart L. Cohen, Matthew A. Barish, Eugenia Gianos, Anise M. Diaz, Safiya Richardson, Dimitrios Giannis, Saurav Chatterjee, Kevin Coppa, Jamie S. Hirsch, Sam Ngu, Sheila N. Firoozan, Thomas McGinn, Alex C. Spyropoulos
Topics & Concepts
MedicineReceiver operating characteristicPulmonary embolismInternal medicineRisk assessmentVenous thromboembolismArea under the curveVenous thrombosisRetrospective cohort studyFramingham Risk ScorePredictive valueCoronavirus disease 2019 (COVID-19)Predictive value of testsThrombosisCohortEmergency medicineComputer scienceComputer securityDiseaseInfectious disease (medical specialty)Venous Thromboembolism Diagnosis and ManagementCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impacts